PMC:4307189 / 30474-31156 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4307189","sourcedb":"PMC","sourceid":"4307189","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4307189","text":"Table 1 Primary findings from the analyses using signaling pathways from Reactome, KEGG and WikiPathway in breast cancer cell-line: SKBR3 (GSE38376)\nPathway # of signaling Pathway of All Distinct All putative Distinct # of other\nsource pathways interest Cross-talks gene-pairs § drug-resistant gene-pairs ¶ signaling\nof interest cross-talks pathways\nREACTOME 23 EGFR 1,083 841 104 97 13\nKEGG 35 ErbB 2,179 1,050 188 99 26\nWikiPathway 63 ErbB 3,084 876 299 96 51\n¶Number of distinct gene-pairs involved in all EGFR/ErbB cross-talks with all other signaling pathways; §Number of distinct gene-pairs commonly involved in all EGFR/ErbB cross-talks and drug resistance.\n","divisions":[{"label":"label","span":{"begin":0,"end":7}},{"label":"caption","span":{"begin":8,"end":149}},{"label":"p","span":{"begin":8,"end":149}},{"label":"table","span":{"begin":150,"end":478}},{"label":"tr","span":{"begin":150,"end":236}},{"label":"th","span":{"begin":150,"end":158}},{"label":"th","span":{"begin":158,"end":173}},{"label":"th","span":{"begin":174,"end":185}},{"label":"th","span":{"begin":186,"end":190}},{"label":"th","span":{"begin":191,"end":200}},{"label":"th","span":{"begin":201,"end":214}},{"label":"th","span":{"begin":215,"end":224}},{"label":"th","span":{"begin":225,"end":236}},{"label":"tr","span":{"begin":237,"end":331}},{"label":"th","span":{"begin":237,"end":244}},{"label":"th","span":{"begin":244,"end":253}},{"label":"th","span":{"begin":254,"end":263}},{"label":"th","span":{"begin":264,"end":276}},{"label":"th","span":{"begin":277,"end":290}},{"label":"th","span":{"begin":291,"end":306}},{"label":"th","span":{"begin":307,"end":320}},{"label":"th","span":{"begin":321,"end":331}},{"label":"tr","span":{"begin":332,"end":366}},{"label":"th","span":{"begin":332,"end":344}},{"label":"th","span":{"begin":344,"end":356}},{"label":"th","span":{"begin":357,"end":366}},{"label":"tr","span":{"begin":367,"end":403}},{"label":"td","span":{"begin":367,"end":375}},{"label":"td","span":{"begin":376,"end":378}},{"label":"td","span":{"begin":379,"end":383}},{"label":"td","span":{"begin":384,"end":389}},{"label":"td","span":{"begin":390,"end":393}},{"label":"td","span":{"begin":394,"end":397}},{"label":"td","span":{"begin":398,"end":400}},{"label":"td","span":{"begin":401,"end":403}},{"label":"tr","span":{"begin":404,"end":438}},{"label":"td","span":{"begin":404,"end":408}},{"label":"td","span":{"begin":409,"end":411}},{"label":"td","span":{"begin":412,"end":416}},{"label":"td","span":{"begin":417,"end":422}},{"label":"td","span":{"begin":423,"end":428}},{"label":"td","span":{"begin":429,"end":432}},{"label":"td","span":{"begin":433,"end":435}},{"label":"td","span":{"begin":436,"end":438}},{"label":"tr","span":{"begin":439,"end":478}},{"label":"td","span":{"begin":439,"end":450}},{"label":"td","span":{"begin":451,"end":453}},{"label":"td","span":{"begin":454,"end":458}},{"label":"td","span":{"begin":459,"end":464}},{"label":"td","span":{"begin":465,"end":468}},{"label":"td","span":{"begin":469,"end":472}},{"label":"td","span":{"begin":473,"end":475}},{"label":"td","span":{"begin":476,"end":478}}],"tracks":[]}